Author:
Dawar Abhishek,Warmoota Rahul
Abstract
Exploration beyond low earth orbit is a major challenge during space missions. The journey brings deleterious changes to the composition of bacterial flora of the spacecraft and compromises the immune system of the crew members significantly. Space exploration reduces immunological competence in crew members and is expected to create harmful alterations in the bacterial flora of the nasal, gastrointestinal, and respiratory tracts, increasing the susceptibility to disease. The pathogenicity character traits of bacteria and other microorganisms that pollute the material of the International Space Station as well as other flight platforms may be modified by the space flight environment, which may affect their vulnerability to antibiotics, which are important ingredients of flights medical setups. In conclusion susceptibility of microbes to antibiotics was affected and measures need to be studied in order to establish precautionary methods for future space missions. In this review we discussed the effect of spaceflights on microbial physiology; various challenges faced by the crew members and spacecraft equipment, and also highlighted methods to overcome these challenges during space flights for ensuring safety of the crew.
Reference84 articles.
1. Ahmad, I. and Khan, M.S.A. (2012). Microscopy in mycological research with especial reference to ultrastructures and biofilm studies. Current microscopy contributions to advances in science and technology. Formatex Research Center, Spain, 646-659.
2. Altenburg, S.D., Nielsen-Preiss, S.M. and Hyman, L.E. (2008). Increased filamentous growth of Candida albicans in simulated microgravity. Genomics, proteomics & bioinformatics, 6(1), 42-50.
3. Andersen, B. and Hollensted, M. (2008). Metabolite production by different Ulocladium species. International journal of food microbiology, 126(1-2), 172-179.
4. Benoit, M.R. and Klaus, D.M. (2007). Microgravity, bacteria, and the influence of motility. Advances in Space Research, 39(7), 1225-1232.
5. Berdy, J. (2005). Bioactive microbial metabolites. The Journal of Antibiotics, 58(1), 1–26.